Imagenebio Stock Analysis
| IMA Stock | 6.94 0.09 1.31% |
ImageneBio's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. ImageneBio's financial risk is the risk to ImageneBio stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that ImageneBio's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which ImageneBio is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of ImageneBio to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, ImageneBio is said to be less leveraged. If creditors hold a majority of ImageneBio's assets, the Company is said to be highly leveraged.
ImageneBio is fairly valued with Real Value of 6.89 and Hype Value of 7.05. The main objective of ImageneBio stock analysis is to determine its intrinsic value, which is an estimate of what ImageneBio is worth, separate from its market price. There are two main types of ImageneBio's stock analysis: fundamental analysis and technical analysis.
The ImageneBio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ImageneBio's ongoing operational relationships across important fundamental and technical indicators.
ImageneBio | Build AI portfolio with ImageneBio Stock |
ImageneBio Stock Analysis Notes
About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 4.33. ImageneBio had not issued any dividends in recent years. The entity had 1:12 split on the 28th of July 2025. To learn more about ImageneBio call Kristin Yarema at 858 345 6265 or check out https://www.inmagenebio.com.ImageneBio Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ImageneBio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ImageneBio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| ImageneBio generated a negative expected return over the last 90 days | |
| ImageneBio has high historical volatility and very poor performance | |
| ImageneBio was previously known as IKNA Old and was traded on NASDAQ Exchange under the symbol IKNA. | |
| The company reported the last year's revenue of 3.5 M. Reported Net Loss for the year was (49.23 M) with profit before taxes, overhead, and interest of 4.3 M. | |
| ImageneBio generates negative cash flow from operations | |
| About 14.0% of the company shares are held by company insiders |
ImageneBio Market Capitalization
The company currently falls under 'Micro-Cap' category with a total capitalization of 91.69 M.Technical Drivers
As of the 9th of January, ImageneBio retains the Standard Deviation of 3.6, risk adjusted performance of (0.01), and Market Risk Adjusted Performance of (0.17). ImageneBio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.ImageneBio Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as ImageneBio price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
ImageneBio Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ImageneBio insiders, such as employees or executives, is commonly permitted as long as it does not rely on ImageneBio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ImageneBio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Erin Butler over a week ago Acquisition by Erin Butler of 22500 shares of ImageneBio at 7.11 subject to Rule 16b-3 | ||
Slattery Joseph P over two weeks ago Acquisition by Slattery Joseph P of 16000 shares of ImageneBio at 5.99 subject to Rule 16b-3 | ||
Slattery Joseph P over two months ago Insider Trading | ||
Marango Jotin over three months ago Disposition of 4630 shares by Marango Jotin of ImageneBio, at 17.16 subject to Rule 16b-3 |
ImageneBio Outstanding Bonds
ImageneBio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ImageneBio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ImageneBio bonds can be classified according to their maturity, which is the date when ImageneBio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| iHeartCommunications 6375 percent Corp BondUS45174HBC07 | View | |
| iHeartCommunications 8375 percent Corp BondUS45174HBD89 | View | |
| iHeartCommunications 475 percent Corp BondUS45174HBG11 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
ImageneBio Predictive Daily Indicators
ImageneBio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ImageneBio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 441.71 | |||
| Daily Balance Of Power | 0.4091 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 6.96 | |||
| Day Typical Price | 6.95 | |||
| Price Action Indicator | 0.025 | |||
| Period Momentum Indicator | 0.09 |
ImageneBio Forecast Models
ImageneBio's time-series forecasting models are one of many ImageneBio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ImageneBio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.ImageneBio Bond Ratings
ImageneBio financial ratings play a critical role in determining how much ImageneBio have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for ImageneBio's borrowing costs.| Piotroski F Score | 5 | Healthy | View |
| Beneish M Score | (3.73) | Unlikely Manipulator | View |
ImageneBio Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the ImageneBio's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of ImageneBio, which in turn will lower the firm's financial flexibility.ImageneBio Corporate Bonds Issued
Most ImageneBio bonds can be classified according to their maturity, which is the date when ImageneBio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ImageneBio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Complementary Tools for ImageneBio Stock analysis
When running ImageneBio's price analysis, check to measure ImageneBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImageneBio is operating at the current time. Most of ImageneBio's value examination focuses on studying past and present price action to predict the probability of ImageneBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImageneBio's price. Additionally, you may evaluate how the addition of ImageneBio to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stocks Directory Find actively traded stocks across global markets |